Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
Public ClinicalTrials.gov record NCT02654236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to see whether heavy drinking will interfere with a specific pathway, called FXR signaling in the liver. The abnormality of this pathway may lead to liver injury in some patients who drink heavily.
Study identification
- NCT ID
- NCT02654236
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2016
- Primary completion
- Aug 31, 2019
- Completion
- Aug 31, 2019
- Last update posted
- Apr 24, 2023
2016 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Alcohol Consumption trials
Other public records listing Alcohol Consumption. Sorted by last update posted; newest first. Not a recommendation.
- NCT06617702: Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial Active, not recruiting
- NCT07657221: Impact of Risk Feedback on Behavioral Trajectories Not yet recruiting
- NCT07557745: uSafeUS+ App Pilot Testing Recruiting
- NCT06136195: Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers Recruiting
- NCT06770556: Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study Recruiting
- NCT07118618: Probenecid Administration for Alcohol Craving and Consumption Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02654236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02654236 live on ClinicalTrials.gov.